Quality improvement in neurology: Neuro-otology quality measurement set
| Autor: | Habib G. Rizk, Marc L. Bennett, Erika A. Woodson, David Morrill, David A. Zapala, Patricia Gerend, Anant M. Shenoy, John G. Oas, Amy Bennett, Susan Barthel, J. Kirk Roberts, Joni K. Doherty, Daniel R. Gold, Yuri Agrawal |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Pediatrics
medicine.medical_specialty Quality management Neurology Population MEDLINE Brain tumor 03 medical and health sciences 0302 clinical medicine medicine Humans Medical diagnosis education Ear Diseases Socioeconomic status education.field_of_study business.industry Cancer medicine.disease Quality Improvement 030220 oncology & carcinogenesis Neurology (clinical) Nervous System Diseases business Neurotology 030217 neurology & neurosurgery |
| Zdroj: | Neurology. 91(15) |
| ISSN: | 1526-632X |
| Popis: | Over 78,000 new CNS tumors are diagnosed each year in the United States, nearly one-third of which are primary malignant brain tumors,1 and the US prevalence of primary brain tumors is approximately 688,000.2 While primary CNS neoplasms represent only 1.4% of new cancer diagnoses, approximately 2.7% of cancer deaths are related to CNS neoplasms,3 and it is estimated that 16,947 deaths will result from primary CNS tumors in 2017.1 Population-based studies have shown that socioeconomic disparities are present within the neuro-oncology community,4–7 highlighting the need for a unified system of quality metrics in this growing field. Toward this end, several authors have published work on quality-based practice and on the inclusion of patient-reported outcomes in brain tumor care.8–12 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|